Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name LAG525
Trade Name
Synonyms LAG-525|Leramilimab
Drug Descriptions

LAG525 (Leramilimab) is a monoclonal antibody that targets LAG3 and blocks interaction with MHC class II molecules, leading to enhanced T-cell response to tumor cells and decreased tumor growth (NCI Drug Dictionary).

DrugClasses Immune Checkpoint Inhibitor 98 LAG3 Antibody 12
CAS Registry Number 2137049-37-5
NCIT ID C122683


  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Canakinumab + LAG525 + Spartalizumab Canakinumab LAG525 Spartalizumab 0 1
Capmatinib + LAG525 + Spartalizumab Capmatinib LAG525 Spartalizumab 0 1
Carboplatin + LAG525 Carboplatin LAG525 0 1
Carboplatin + LAG525 + Spartalizumab Carboplatin LAG525 Spartalizumab 0 1
LAG525 LAG525 0 2
LAG525 + MCS110 + Spartalizumab LAG525 MCS110 Spartalizumab 0 1
LAG525 + PBF-509 + Spartalizumab LAG525 PBF-509 Spartalizumab 0 1
LAG525 + Spartalizumab LAG525 Spartalizumab 0 2

Additional content available in CKB BOOST